Migdal Insurance & Financial Holdings’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$24.2M Buy
130,575
+130,043
+24,444% +$24.1M 0.29% 61
2025
Q1
$111K Sell
532
-1,504
-74% -$314K ﹤0.01% 244
2024
Q4
$362K Sell
2,036
-326
-14% -$58K 0.01% 184
2024
Q3
$466K Sell
2,362
-186
-7% -$36.7K 0.01% 178
2024
Q2
$436K Sell
2,548
-871
-25% -$149K 0.01% 186
2024
Q1
$623K Sell
3,419
-7,685
-69% -$1.4M 0.01% 163
2023
Q4
$1.72M Buy
11,104
+7,661
+223% +$1.19M 0.03% 123
2023
Q3
$518K Buy
3,443
+1,420
+70% +$214K 0.01% 186
2023
Q2
$273K Sell
2,023
-941
-32% -$127K 0.01% 212
2023
Q1
$471K Sell
2,964
-249
-8% -$39.6K 0.01% 190
2022
Q4
$520K Buy
3,213
+219
+7% +$35.4K 0.01% 164
2022
Q3
$407K Buy
2,994
+954
+47% +$130K 0.01% 184
2022
Q2
$312K Buy
2,040
+601
+42% +$91.9K 0.01% 208
2022
Q1
$235K Sell
1,439
-462
-24% -$75.4K ﹤0.01% 260
2021
Q4
$258K Sell
1,901
-812
-30% -$110K ﹤0.01% 276
2021
Q3
$293K Buy
2,713
+487
+22% +$52.6K ﹤0.01% 269
2021
Q2
$251K Buy
2,226
+1,522
+216% +$172K ﹤0.01% 304
2021
Q1
$76K Buy
704
+56
+9% +$6.05K ﹤0.01% 499
2020
Q4
$69K Sell
648
-59
-8% -$6.28K ﹤0.01% 462
2020
Q3
$62K Buy
707
+198
+39% +$17.4K ﹤0.01% 543
2020
Q2
$50K Sell
509
-196
-28% -$19.3K ﹤0.01% 531
2020
Q1
$54K Sell
705
-767
-52% -$58.7K ﹤0.01% 471
2019
Q4
$129K Sell
1,472
-3,670
-71% -$322K ﹤0.01% 465
2019
Q3
$384K Buy
5,142
+1,565
+44% +$117K 0.01% 358
2019
Q2
$256K Buy
3,577
+2,102
+143% +$150K 0.01% 433
2019
Q1
$117K Sell
1,475
-16
-1% -$1.27K ﹤0.01% 490
2018
Q4
$136K Sell
1,491
-13,375
-90% -$1.22M ﹤0.01% 433
2018
Q3
$1.41M Buy
14,866
+6,497
+78% +$614K 0.03% 269
2018
Q2
$768K Buy
8,369
+4,323
+107% +$397K 0.02% 275
2018
Q1
$379K Sell
4,046
-712
-15% -$66.7K 0.01% 306
2017
Q4
$457K Sell
4,758
-853
-15% -$81.9K 0.01% 231
2017
Q3
$495K Sell
5,611
-1,341
-19% -$118K 0.01% 218
2017
Q2
$504K Sell
6,952
-1,744
-20% -$126K 0.01% 199
2017
Q1
$569K Sell
8,696
-1,637
-16% -$107K 0.01% 193
2016
Q4
$648K Buy
+10,333
New +$648K 0.02% 168